Forest Laboratories Inc.

NYS : FRX
Pharmaceuticals
New York NY
IW Best50N/A
2012 Revenue (US$ Millions)$4,586
2011 Revenue (US$ Millions)$4,420
Revenue Growth (%)3.76%
Net Income (US$ Millions)$979
Common Shares Outstanding (Millions)$266
Earnings Per Share (US$)$3.57
Total Equity (US$ Millions)$5,677
Profit Growth (%)-6.47
Profit Margin (%)21.35%
Return On Equity (%)17.80%
Long Term Debt (US$ Millions)($99,999,999)
Debt To Equity Ratio (%)-99%
Market Capitalization (US$ Millions)$9,214
Total Assets (US$ Millions)$7,492
Return on Assets (%)14.14
Current Assets (US$ Millions)$3,586
Inventories (US$ Millions)$298
Current Liabilities (US$ Millions)$929
Cost of Goods Sold (US$ Millions)$998
Asset Turnover0.61
Inventory Turnover2.66